Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$71,110
+$10,707 QoQ
Shares Held
4,478
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#641
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $190,507 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (37.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
4,649 | $74,523 | |
| 2 | VTRS |
Viatris Inc
This page
|
4,478 | $71,110 | |
| 3 | ZTS |
Zoetis Inc.
|
500 | $35,930 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
119 | $2,928 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4 | $2,167 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11 | $1,853 | |
| 7 | ALKS |
Alkermes plc.
|
20 | $1,048 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
28 | $948 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,110 | 4,478 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $60,403 | 4,471 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $55,551 | 4,462 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $46,223 | 4,669 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $44,953 | 5,034 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $41,677 | 4,785 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $60,482 | 4,858 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $56,308 | 4,850 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $51,459 | 4,841 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $58,207 | 4,875 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $52,352 | 4,834 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $43,985 | 4,461 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $44,420 | 4,451 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $34,987 | 3,637 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $47,525 | 4,270 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $39,481 | 4,634 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $50,046 | 4,780 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $49,177 | 4,520 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $65,836 | 4,866 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $69,064 | 5,097 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $69,292 | 4,849 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $64,373 | 4,608 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $91,469 | 4,881 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||